Growth Metrics

Qiagen (QGEN) Accumulated Expenses (2016 - 2024)

Historic Accumulated Expenses for Qiagen (QGEN) over the last 16 years, with Q4 2024 value amounting to $406.9 million.

  • Qiagen's Accumulated Expenses fell 7.17% to $406.9 million in Q4 2024 from the same period last year, while for Dec 2024 it was $406.9 million, marking a year-over-year decrease of 7.17%. This contributed to the annual value of $406.9 million for FY2024, which is 7.17% down from last year.
  • As of Q4 2024, Qiagen's Accumulated Expenses stood at $406.9 million, which was down 7.17% from $407.2 million recorded in Q4 2023.
  • Qiagen's Accumulated Expenses' 5-year high stood at $568.6 million during Q4 2021, with a 5-year trough of $406.9 million in Q4 2024.
  • In the last 5 years, Qiagen's Accumulated Expenses had a median value of $411.5 million in 2020 and averaged $456.1 million.
  • As far as peak fluctuations go, Qiagen's Accumulated Expenses soared by 3818.8% in 2021, and later crashed by 1626.14% in 2023.
  • Over the past 5 years, Qiagen's Accumulated Expenses (Quarter) stood at $411.5 million in 2020, then soared by 38.19% to $568.6 million in 2021, then dropped by 14.49% to $486.2 million in 2022, then dropped by 16.26% to $407.2 million in 2023, then decreased by 0.07% to $406.9 million in 2024.
  • Its last three reported values are $406.9 million in Q4 2024, $407.2 million for Q4 2023, and $486.2 million during Q4 2022.